According to Sino Biopharmaceutical's latest financial reports the company's current earnings are C$3.85 Billion. In 2020 the company made an earning of C$1.05 Billion a decrease over its 2019 earnings that were of C$1.15 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2021 (TTM) | C$2.58 B | 145.27% |
2020 | C$1.05 B | -8.89% |
2019 | C$1.15 B | -52.21% |
2018 | C$2.42 B | 168.27% |
2017 | C$0.90 B | 25.86% |
2016 | C$0.71 B | 9.37% |
2015 | C$0.65 B | 25.86% |
2014 | C$0.52 B | 32.83% |
2013 | C$0.39 B | 19.1% |
2012 | C$0.32 B | 82.18% |
2011 | C$0.18 B |